ImageneBio, Inc. Net Cash Provided by (Used in) Continuing Operations
ImageneBio, Inc. (IMA) reported Net Cash Provided by (Used in) Continuing Operations of $13.20 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2021-05-13
- ImageneBio, Inc. net cash provided by (used in) continuing operations for the quarter ending 2021-03-31 was $13.20M.
| Period end | Net Cash Provided by (Used in) Continuing Operations 3 month |
|---|---|
| 2021-03-31 | $13.20M 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |